Form 8-K - Current report:
SEC Accession No. 0000950170-25-089218
Filing Date
2025-06-24
Accepted
2025-06-24 07:05:28
Documents
13
Period of Report
2025-06-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amrn-20250620.htm   iXBRL 8-K 66713
2 EX-10.1 amrn-ex10_1.htm EX-10.1 636081
3 EX-99.1 amrn-ex99_1.htm EX-99.1 60530
4 GRAPHIC img114078973_0.jpg GRAPHIC 55155
  Complete submission text file 0000950170-25-089218.txt   1060902

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amrn-20250620.xsd EX-101.SCH 32938
16 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20250620_htm.xml XML 4958
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 251066672
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)